文献速递青光眼

英国莫菲尔德眼科医院急性原发性闭角发作后的长期结局:病例系列

Long-term outcomes after acute primary angle closure: case series from Moorfields Eye Hospital, UK.
PubMed 文献 · Br J Ophthalmol · 2024-11-22

该回顾性观察性病例系列纳入英国三级转诊单位莫菲尔德眼科医院的117例连续患者(121眼)急性原发性闭角(APAC)发作,报告长期视力和眼压结局及所需治疗。多数患者(73%)最终随访视力≥6/12,仅15%(17眼)患眼达WHO严重视力损伤标准,其中6.6%(8眼)由青光眼所致。延迟就诊与需进一步药物治疗相关(OR=2.83),行超声乳化术者失明(OR 0.18)、眼压升高(OR 0.10)及需进一步药物治疗(OR 0.34)风险更低,高龄与更差视力结局相关(OR 1.26)。

要点

  • 73%患者最终随访视力≥6/12,达英国驾驶标准。
  • 15%(17眼)患眼达WHO严重视力损伤,其中6.6%(8眼)由青光眼所致。
  • 超声乳化术与较低失明、眼压升高及需进一步药物治疗风险相关。

核心结论

  • 在该以白种人为主的英国患者群体中,APAC导致较低的长期视力和治疗负担。
  • 作者认为超声乳化术作为治疗可能改善视力结局并减少进一步降眼压治疗的需求。

研究设计与样本

  • 回顾性观察性病例系列,纳入英国三级转诊单位莫菲尔德眼科医院117例连续患者(121眼)的APAC发作。

主要发现

  • 73%患者最终随访视力≥6/12,达英国驾驶标准。
  • 15%(17眼)患眼达WHO严重视力损伤标准,其中6.6%(8眼)由青光眼所致。
  • 延迟就诊与需进一步药物治疗相关(OR=2.83,95%CI 1.09至7.40,p=0.03)。
  • 行超声乳化术者失明风险更低(OR 0.18,95%CI 0.05至0.69,p=0.01)、眼压升高风险更低(OR 0.10,95%CI 0.01至0.75,p=0.02)、需进一步药物治疗风险更低(OR 0.34,95%CI 0.12至0.99,p=0.04)。
  • 高龄与更差视力结局相关(OR 1.26,95%CI 1.08至1.48,p<0.01)。

临床怎么用

  • 作者认为超声乳化术作为治疗可能改善视力结局并减少进一步降眼压治疗的需求。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is limited data regarding the morbidity and progression to primary angle closure glaucoma in those presenting with acute primary angle closure (APAC) in the UK. We aim to report on the vision and intraocular pressure (IOP) outcomes and treatment required after an APAC episode and to identify any risk factors that could predict worse outcomes. METHODS: A retrospective observational case series review including 117 consecutive patients (121 eyes) attending Moorfields Eye Hospital, at a tertiary referral unit in the UK, with APAC was performed. RESULTS: Most patients (73%) had visual acuities of ≥6/12, meeting the UK driving standard, at the final follow-up. Only 15% (17 eyes) had severe visual impairment, as defined by the WHO, in the affected eye, of which 6.6% (eight eyes) were due to glaucoma. The delayed presentation was linked to a higher need for further medical treatment (OR=2.83, 95% CI 1.09 to 7.40, p=0.03). Patients who underwent phacoemulsification were at lower risk of having blindness in the affected eye (OR 0.18, 95% CI 0.05 to 0.69, p=0.01), having elevated IOP (OR 0.10, 95% CI 0.01 to 0.75, p=0.02) or requiring further medical treatment (OR 0.34, 95% CI 0.12 to 0.99, p=0.04). Older age (OR 1.26, 95% CI 1.08 to 1.48, p<0.01) was associated with worse visual outcomes. CONCLUSIONS: APAC causes low long-term visual and treatment morbidity in this largely Caucasian patient group in the UK. Phacoemulsification as a treatment may enhance visual outcomes and reduce the need for further IOP-lowering treatment.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Hamid S, Matarazzo F, Sun Z, et al. Long-term outcomes after acute primary angle closure: case series from Moorfields Eye Hospital, UK. Br J Ophthalmol. 2024. PMID: 38740430. doi:10.1136/bjo-2023-324748

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。